Tevogen Bio Holdings Inc.

NasdaqGM:TVGN Stock Report

Market Cap: US$196.1m

Tevogen Bio Holdings Management

Management criteria checks 1/4

Tevogen Bio Holdings' CEO is Ryan Saadi, appointed in Feb 2024, has a tenure of less than a year. total yearly compensation is $501.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 67.55% of the company’s shares, worth $132.44M. The average tenure of the management team and the board of directors is 0.9 years and 2.4 years respectively.

Key information

Ryan Saadi

Chief executive officer

US$501.0k

Total compensation

CEO salary percentage100.0%
CEO tenureless than a year
CEO ownership67.6%
Management average tenureless than a year
Board average tenure2.4yrs

Recent management updates

Recent updates

Tevogen Bio Claims $10 Billion IP Potential But Hinges On Monetization

Dec 16

CEO Compensation Analysis

How has Ryan Saadi's remuneration changed compared to Tevogen Bio Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$4m

Jun 30 2024n/an/a

-US$2m

Mar 31 2024n/an/a

-US$19m

Dec 31 2023US$501kUS$501k

-US$60m

Sep 30 2023n/an/a

-US$63m

Jun 30 2023n/an/a

-US$64m

Mar 31 2023n/an/a

-US$47m

Dec 31 2022US$454kUS$453k

-US$22m

Compensation vs Market: Ryan's total compensation ($USD501.00K) is below average for companies of similar size in the US market ($USD1.38M).

Compensation vs Earnings: Ryan's compensation has increased whilst the company is unprofitable.

CEO

Ryan Saadi (59 yo)

less than a year

Tenure

US$501,000

Compensation

Dr. Ryan Saadi, M.D., M.P.H., has been Chief Executive Officer and Chairperson Tevogen Bio Holdings Inc. since February 14, 2024. He served as Chief Executive Officer and Chairperson of Tevogen Bio beginni...

Leadership Team

NamePositionTenureCompensationOwnership
Ryan Saadi
Co-Founderless than a yearUS$501.00k67.55%
$ 132.4m
Kirti Desai
Chief Financial Officerless than a yearUS$300.00k5.54%
$ 10.9m
Neal Flomenberg
Chief Scientific Officer and Global R&D Lead2.5yrsUS$2.93m2.43%
$ 4.8m
Stephen Chen
Chief Technical Officer2.8yrsno datano data
Mittul Mehta
Chief Information Officer & Head of Tevogen.ai1.2yrsno datano data
Tapan Shah
Head of Investor Relations & Corporate Developmentless than a yearno datano data
Sadiq Khan
Chief Commercial Officerless than a yearno datano data

0.9yrs

Average Tenure

64.5yo

Average Age

Experienced Management: TVGN's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Ryan Saadi
Co-Founderless than a yearUS$501.00k67.55%
$ 132.4m
Manmohan Patel
Member of Advisory Board3yrsno data5.5%
$ 10.8m
Bruce Cooper
Member of Advisory Board3yrsno datano data
Victor Sordillo
Independent Director1.5yrsUS$253.46k0.14%
$ 268.8k
Keow Lin Goh
Independent Director2.4yrsno data0.11%
$ 217.2k
Jeffrey Feike
Independent Directorless than a yearno data0.33%
$ 651.6k
Susan Podlogar
Independent Director2.4yrsno data0%
$ 0
Curtis Patton
Independent Directorless than a yearno data0.55%
$ 1.1m
Sten Vermund
Member of Advisory Board3yrsno datano data
Kendell Sprott
Member of Advisory Board2.6yrsno datano data
Afshin Beheshti
Member of Advisory Boardless than a yearno datano data

2.4yrs

Average Tenure

71yo

Average Age

Experienced Board: TVGN's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 09:25
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tevogen Bio Holdings Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siddharth RajeevFundamental Research Corp.